Mosquitoes Are a Choice
a day ago
- Mosquito-borne diseases like dengue are resurging in the US due to climate change and pesticide resistance, with nearly 4,000 dengue cases in 2024.
- Genetic engineering of mosquitoes (Oxitec's lethal gene) can collapse local populations by causing female offspring to die, but faced 15 years of regulatory delays across USDA, FDA, and EPA.
- Wolbachia-infected mosquitoes offer an alternative non-GM method that makes mosquitoes resistant to viruses and can suppress populations; MosquitoMate received full commercial registration in 2024.
- The US regulatory framework for biotech is outdated (1986 Coordinated Framework), causing jurisdictional confusion and long review times, hindering deployment of effective mosquito control.
- Reforms like increased agency staffing and fee-based review systems could speed up approvals, as seen with FDA drug reviews, but political will is needed to eliminate mosquito-borne disease.